Cargando…
Targeting the AKT pathway: Repositioning HIV protease inhibitors as radiosensitizers
Cellular resistance in tumour cells to different therapeutic approaches has been a limiting factor in the curative treatment of cancer. Resistance to therapeutic radiation is a common phenomenon which significantly reduces treatment options and impacts survival. One of the mechanisms of acquiring re...
Autores principales: | Goda, Jayant S., Pachpor, Tejaswini, Basu, Trinanjan, Chopra, Supriya, Gota, Vikram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859124/ https://www.ncbi.nlm.nih.gov/pubmed/27121513 http://dx.doi.org/10.4103/0971-5916.180201 |
Ejemplares similares
-
Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects
por: Hegde, Manasa Manjunath, et al.
Publicado: (2023) -
Counteracting Akt Activation by HIV Protease Inhibitors in Monocytes/Macrophages
por: Pasquereau, Sébastien, et al.
Publicado: (2018) -
Repositioning HIV protease inhibitors and nucleos(t)ide RNA polymerase inhibitors for the treatment of SARS-CoV-2 infection and COVID-19
por: von Hentig, Nils
Publicado: (2021) -
Synergistic locoregional chemoradiotherapy using a composite liposome-in-gel system as an injectable drug depot
por: GuhaSarkar, Shruti, et al.
Publicado: (2016) -
Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma
por: Liu, Wei-Lin, et al.
Publicado: (2014)